DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,444,322 | +78.7% | 300,902 | +56.3% | 0.01% | +66.7% |
Q2 2023 | $2,487,164 | +43.3% | 192,505 | +8.8% | 0.00% | +50.0% |
Q1 2023 | $1,735,114 | -42.0% | 176,872 | -37.1% | 0.00% | -50.0% |
Q4 2022 | $2,991,404 | -6.0% | 281,147 | -7.8% | 0.00% | 0.0% |
Q3 2022 | $3,184,000 | +25.8% | 304,950 | +51.7% | 0.00% | +33.3% |
Q2 2022 | $2,531,000 | +329.0% | 201,014 | +419.5% | 0.00% | +200.0% |
Q2 2018 | $590,000 | -59.5% | 38,697 | -47.3% | 0.00% | -66.7% |
Q1 2018 | $1,458,000 | -26.7% | 73,430 | -31.0% | 0.00% | -40.0% |
Q4 2017 | $1,990,000 | – | 106,402 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |